Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 47.48

From 52W high−28.59%

Volume1.94M

Market capCNY 7.58B

P/E (TTM)26.7x

P/S (TTM)6.3x

Div yield1.01%

Key dataSep 18, 2026

Open

CNY 47.48

From 52W high

−28.59%

Volume

1.94M

Market cap

CNY 7.58B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.6x

P/E (TTM)

26.7x

RSI (14)

55.9

MomentumView details →

1D Return

−5.82%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

26.7x

EV/EBITDA

20.6x

EV/Sales

6.2x

P/S (TTM)

6.3x

P/B (TTM)

2.6x

ProfitabilityView details →

Gross Margin

74.89%

Net Margin

20.29%

EBITDA Margin

30.23%

ROE (TTM)

9.18%

ROA (TTM)

7.26%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+0.87%

EPS YoY

+22.90%

FCF YoY

+45.10%

Revenue CAGR 3Y

+4.39%

EPS CAGR 3Y

−7.36%

EBITDA YoY

—

MomentumView details →

1D Return

−5.82%

YTD Return

—

1Y Return

—

RSI (14)

55.9

vs 50D SMA

+0.88%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

3.82x

Quick Ratio

3.38x

Div Yield

1.01%

Div Rate

CNY 0.49

Div Growth 1Y

+13.95%

EarningsView details →

EPS (Actual)

CNY 0.45

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

0.11%

Financials snapshotView financials →

Revenue (TTM)

1.35B

Net Income (TTM)

274.30M

Op. CF (TTM)

311.54M

Latest newsMore news →

Yuandong Biologics announced it will repurchase and cancel 257,454 shares of its 2024 employee stock ownership plan that failed to unlock in the second vesting period, at a repurchase price of 21.63 yuan per share, reducing total shares from 176,532,300 to 176,274,800.13d ago

Similar companies

Immunovant, Inc.IMVT Alphamab Oncology09966.HK CStone Pharmaceuticals02616.HK Ionis Pharmaceuticals, Inc.IONS CARsgen Therapeutics Holdings Limited02171.HK Longbio-b01779.HK Find similar companies →

Latest newsMore news →

Yuandong Biologics announced it will repurchase and cancel 257,454 shares of its 2024 employee stock ownership plan that failed to unlock in the second vesting period, at a repurchase price of 21.63 yuan per share, reducing total shares from 176,532,300 to 176,274,800.13d ago